Description

Summary of multi-target pharmacology of phytocannabinoids relevant to epilepsy is presented. The polypharmacological profile of these compounds may explain their broad-spectrum anticonvulsant activity.

Figure 499

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 499: Summary of multi-target pharmacology of phytocannabinoids relevant to epilepsy is presented. The polypharmacological profile of these compounds may explain their broad-spectrum anticonvulsant activity.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Summary of multi-target pharmacology of phytocannabinoids relevant to epilepsy is presented. The polypharmacological profile of these compounds may explain their broad-spectrum anticonvulsant activity." />
  <figcaption>Figure 499. Summary of multi-target pharmacology of phytocannabinoids relevant to epilepsy is presented. The polypharmacological profile of these compounds may explain their broad-spectrum anticonvulsant activity.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Preuves associées

CBD pour Insomnie

Note A · 103 études